Spai Health (00314) is expected to achieve a net profit of 41 million to 44 million yuan in the first half of the year, turning a year-on-year loss into a profit

According to the Zhitong Finance App, Spike Health (00314) announced that the group expects a net profit of 41 million to 44 million yuan in the first half of 2026, compared to a net loss of about 81.1 million yuan for the same period in 2025. The net profit from normalization was 6 million to 7 million yuan, while the net loss from normalization was about 12 million yuan for the same period in 2025.

According to the announcement, the main reason for turning a loss into profit was: (i) the Group's core business (i.e. corporate insurance service business and doctor research assistance business) achieved strong growth; (ii) a rise in the share of core business with high gross margin, which led to an increase in the Group's gross margin; (iii) a reduction in sales and administrative expenses due to the implementation of a series of measures to improve quality and efficiency; (iv) the sale of subsidiaries in the first half of 2026 generated revenue; and (v) a reduction in share-based remuneration.